Additionally, C12 treatment led to a reduction in mitochondrial ROS levels (Supplementary Fig. 5i), suggesting that SIRT3 activation also promotes the activation of antioxidant defenses in ALS MNs. Here, SIRT3 is linked to amyotrophic lateral sclerosis.